Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram
Ting Sun et al.
CELL COMMUNICATION AND SIGNALING (2020)
Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification
Wencheng Wu et al.
ADVANCED MATERIALS (2020)
Controlled release of anti-VEGF by redox-responsive polydopamine nanoparticles
Pengfei Jiang et al.
NANOSCALE (2020)
Enhanced Tumor-Specific Disulfiram Chemotherapy by In Situ Cu2+ Chelation-Initiated Nontoxicity-to-Toxicity Transition
Wencheng Wu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Versatile Polydopamine Platforms: Synthesis and Promising Applications for Surface Modification and Advanced Nanomedicine
Wei Cheng et al.
ACS NANO (2019)
PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges
Mohammad A. Khan et al.
DRUG DISCOVERY TODAY (2019)
JQ1-Loaded Polydopamine Nanoplatform Inhibits c-MYC/Programmed Cell Death Ligand 1 to Enhance Photothermal Therapy for Triple-Negative Breast Cancer
Ying Tian et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Tumor-Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel-Enhanced Immunotherapy with Polarization toward M1-Type Macrophages on Triple Negative Breast Cancers
Lv Chen et al.
ADVANCED MATERIALS (2019)
The controllable growth of ultrathin MnO2 on polydopamine nanospheres as a single nanoplatform for the MRI-guided synergistic therapy of tumors
Yanhong Sun et al.
JOURNAL OF MATERIALS CHEMISTRY B (2019)
Simultaneous Fenton-like Ion Delivery and Glutathione Depletion by MnO2-Based Nanoagent to Enhance Chemodynamic Therapy
Li-Sen Lin et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Mitochondria-Targeting Polydopamine Nanocomposites as Chemophotothermal Therapeutics for Cancer
Zhuo Wang et al.
BIOCONJUGATE CHEMISTRY (2018)
Chemotherapy induces enrichment of CD47+/CD73+/PDL1+ immune evasive triple-negative breast cancer cells
Debangshu Samanta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers
Wu Chen et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Cu2+-Loaded Polydopamine Nanoparticles for Magnetic Resonance Imaging-Guided pH- and Near-Infrared-Light-Stimulated Thermochemotherapy
Rui Ge et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
On the interaction of copper(II) with disulfiram
David J. Lewis et al.
CHEMICAL COMMUNICATIONS (2014)
Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram)
Boris Cvek
DRUG DISCOVERY TODAY (2012)
Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines
Xiaoxia Guo et al.
CANCER LETTERS (2010)
Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
Daniel P. Silver et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Mussel-inspired surface chemistry for multifunctional coatings
Haeshin Lee et al.
SCIENCE (2007)
Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity
Di Chen et al.
CANCER RESEARCH (2006)
Share Paper
